Back
Legend Biotech Corp (LEGN)
BiotechnologyLEGN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$19.12
+2.14%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-0.81
ROE
-25.2%
Gross margin
55.0%
Debt/Equity
0.40x
Revenue growth
56.5%
Legend Biotech Corp — company intelligence
Earnings surprises
Q2 2026$0.18 vs $0.08 est+135.6%
Q1 2026$-0.30 vs $-0.02 est-1295.3%
Q4 2025$-0.16 vs $-0.11 est-44.5%
Q3 2025$-0.22 vs $-0.09 est-155.5%
Analyst consensus · 23 analysts
17 Buy6 Hold0 Sell
Updated Oct 7, 2026
Insider activity · 90 days
3 buys1 sellnet +1,151,014 shares
Santos Carlos ESell 5,430 · Sep 21, 2026
Santos Carlos EBuy 19,676 · Sep 21, 2026
Zhang IngridBuy 1,131,860 · Sep 15, 2026
Recent SEC filings
4 — Insider transaction reportSep 23, 2026
4 — Insider transaction reportSep 16, 2026
4 — Insider transaction reportAug 18, 2026
Latest news
Sector Update: Healthcare Stocks Steady Late Afternoon — Yahoo · 1w ago
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma — Yahoo · 1w ago
HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $65 Price Target — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.